Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha.
Korkmaz
C
C
Temiz
G
G
Cetinbas
F
F
Büyükkidan
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003882:Dermatomyositis / Q000150:complications* / Q000628:therapy; D006801:Humans; D007040:Hypoventilation / Q000209:etiology* / Q000628:therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D012121:Respiration, Artificial; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab